Details for Patent: 4,873,080

✉ Email this page to a colleague

Summary for Patent: 4,873,080

Title:	Oral anti-diabetic pharmaceutical compositions and the preparation thereof
Abstract:	Galenic compositions containing an oral antidiabetic agent and having an improved release of active substance as well as processes for producing these compositions are provided. The pharmaceutical compositions are characterized in that the onset of the activity and the duration of activity are adapted to the particular needs of diabetics with regard to proper control of metabolism and the associated proper release of insulin. A basic or acidic excipient in a solvent is added to the anti-diabetically active substance in a quantity such that the active substance is made soluble, and then a solubilizing agent is added. The solution is applied to a water-insoluble carrier, the solvent is evaporated, and the residue is further processed to yield the various compositions.
Inventor(s):	Brickl; Rolf (Warthausen, DE), Schepky; Gottfried (Biberach, DE), Rupprecht; Eckhard (Aulendorf-Tannhausen, DE), Greischel; Andreas (Biberach, DE)
Assignee:	Dr. Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:	07/103,524
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 4,873,080

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 4,873,080

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	3320583	Jun 08, 1983

International Family Members for US Patent 4,873,080

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	49886	⤷ Sign Up
Australia	2924184	⤷ Sign Up
Australia	562803	⤷ Sign Up
Canada	1228300	⤷ Sign Up
German Democratic Republic	223360	⤷ Sign Up
Germany	3320583	⤷ Sign Up
Germany	3481170	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.